TRIB logo

Trinity Biotech (TRIB) Total Liabilities

Annual Total Liabilities

$83.38 M
-$10.90 M-11.56%

December 31, 2023


Summary


Performance

TRIB Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTRIBbalance sheetmetrics:

Quarterly Total Liabilities

$123.79 M
+$33.00 K+0.03%

September 30, 2024


Summary


Performance

TRIB Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTRIBbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

TRIB Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.6%+52.7%
3 y3 years-37.1%+1.5%
5 y5 years-22.5%-4.4%

TRIB Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-30.1%at lowat high+52.7%
5 y5-year-37.1%at low-9.1%+52.7%
alltimeall time-44.3%+4804.9%-20.0%+7181.6%

Trinity Biotech Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$123.79 M(+0.0%)
Jun 2024
-
$123.75 M(+9.4%)
Mar 2024
-
$113.16 M(+35.7%)
Dec 2023
$83.38 M(-11.6%)
$83.38 M(+2.8%)
Sep 2023
-
$81.08 M(-2.7%)
Jun 2023
-
$83.37 M(-14.7%)
Mar 2023
-
$97.78 M(+3.7%)
Dec 2022
$94.28 M(-20.9%)
$94.28 M(+3.3%)
Sep 2022
-
$91.26 M(-0.1%)
Jun 2022
-
$91.32 M(-18.7%)
Mar 2022
-
$112.38 M(-5.7%)
Dec 2021
$119.21 M(-10.1%)
$119.21 M(-2.3%)
Sep 2021
-
$121.97 M(-2.6%)
Jun 2021
-
$125.22 M(-8.0%)
Mar 2021
-
$136.11 M(+2.6%)
Dec 2020
$132.62 M(+5.0%)
$132.62 M(+2.8%)
Sep 2020
-
$129.00 M(-0.3%)
Jun 2020
-
$129.44 M(+0.8%)
Mar 2020
-
$128.36 M(+1.6%)
Dec 2019
$126.36 M(+17.4%)
$126.36 M(-5.9%)
Sep 2019
-
$134.32 M(+1.3%)
Jun 2019
-
$132.63 M(+3.2%)
Mar 2019
-
$128.48 M(+19.4%)
Dec 2018
$107.61 M(-15.8%)
$107.61 M(-6.6%)
Sep 2018
-
$115.24 M(-9.8%)
Jun 2018
-
$127.75 M(-0.9%)
Mar 2018
-
$128.90 M(+0.9%)
Dec 2017
$127.78 M(-9.3%)
$127.78 M(-7.6%)
Sep 2017
-
$138.24 M(+0.2%)
Jun 2017
-
$137.93 M(+1.5%)
Mar 2017
-
$135.86 M(-3.6%)
Dec 2016
$140.87 M(-6.0%)
$140.87 M(-6.1%)
Sep 2016
-
$150.07 M(+2.0%)
Jun 2016
-
$147.11 M(-0.3%)
Mar 2016
-
$147.56 M(-1.5%)
Dec 2015
$149.79 M(+226.6%)
$149.79 M(+3.7%)
Sep 2015
-
$144.38 M(-6.7%)
Jun 2015
-
$154.70 M(+239.7%)
Mar 2015
-
$45.54 M(-0.7%)
Dec 2014
$45.87 M(+5.5%)
$45.87 M(+8.6%)
Sep 2014
-
$42.22 M(-0.3%)
Jun 2014
-
$42.34 M(+6.1%)
Mar 2014
-
$39.90 M(-8.2%)
Dec 2013
$43.48 M(+55.1%)
$43.48 M(-9.0%)
Sep 2013
-
$47.75 M(+66.8%)
Jun 2013
-
$28.63 M(-0.5%)
Mar 2013
-
$28.78 M(+2.7%)
Dec 2012
$28.03 M(+39.0%)
$28.03 M(+12.8%)
Sep 2012
-
$24.85 M(+2.4%)
Jun 2012
-
$24.27 M(+7.1%)
Mar 2012
-
$22.67 M(+12.4%)
Dec 2011
$20.17 M(+3.0%)
$20.17 M(-1.8%)
Sep 2011
-
$20.54 M(-1.9%)
Jun 2011
-
$20.94 M(-0.7%)
Mar 2011
-
$21.08 M(+7.6%)
DateAnnualQuarterly
Dec 2010
$19.59 M(-63.1%)
$19.59 M(-7.8%)
Sep 2010
-
$21.24 M(+3.3%)
Jun 2010
-
$20.57 M(-59.1%)
Mar 2010
-
$50.31 M(-5.3%)
Dec 2009
$53.10 M(-16.5%)
$53.10 M(-2.0%)
Sep 2009
-
$54.16 M(-8.3%)
Jun 2009
-
$59.09 M(+3.1%)
Mar 2009
-
$57.32 M(-9.9%)
Dec 2008
$63.60 M(-19.6%)
$63.60 M(-6.2%)
Sep 2008
-
$67.84 M(-2.3%)
Jun 2008
-
$69.47 M(-6.3%)
Mar 2008
-
$74.17 M(-6.3%)
Dec 2007
$79.13 M(-3.3%)
$79.13 M(+9.1%)
Jun 2007
-
$72.54 M(-4.3%)
Mar 2007
-
$75.83 M(-7.4%)
Dec 2006
$81.87 M(+60.6%)
$81.87 M(-0.8%)
Sep 2006
-
$82.57 M(-0.0%)
Jun 2006
-
$82.59 M(+91.5%)
Mar 2006
-
$43.14 M(-15.4%)
Dec 2005
$50.98 M(+47.0%)
$50.98 M(+9.6%)
Sep 2005
-
$46.53 M(+37.7%)
Jun 2005
-
$33.79 M(-2.2%)
Mar 2005
-
$34.54 M(-0.4%)
Dec 2004
$34.69 M(-8.3%)
$34.69 M(-6.3%)
Sep 2004
-
$37.02 M(-2.9%)
Jun 2004
-
$38.12 M(-5.1%)
Mar 2004
-
$40.16 M(+6.2%)
Dec 2003
$37.83 M(+40.4%)
$37.83 M(-4.1%)
Sep 2003
-
$39.43 M(+85.5%)
Jun 2003
-
$21.26 M(-19.1%)
Mar 2003
-
$26.28 M(-2.5%)
Dec 2002
$26.95 M(+31.5%)
$26.95 M(+31.6%)
Sep 2002
-
$20.48 M(+10.1%)
Jun 2002
-
$18.60 M(-9.4%)
Mar 2002
-
$20.53 M(+0.1%)
Dec 2001
$20.50 M(+68.2%)
$20.50 M(+61.1%)
Sep 2001
-
$12.72 M(-8.9%)
Jun 2001
-
$13.96 M(+21.2%)
Mar 2001
-
$11.52 M(-5.5%)
Dec 2000
$12.19 M(-45.4%)
$12.19 M(+11.1%)
Sep 2000
-
$10.97 M(-22.9%)
Jun 2000
-
$14.22 M(-35.2%)
Mar 2000
-
$21.94 M(-1.7%)
Dec 1999
$22.32 M(-26.6%)
$22.32 M(-18.8%)
Sep 1999
-
$27.50 M(-8.0%)
Jun 1999
-
$29.90 M(+6.8%)
Mar 1999
-
$28.00 M(-7.9%)
Dec 1998
$30.41 M(+73.8%)
$30.41 M(+2.1%)
Sep 1998
-
$29.80 M(+63.7%)
Jun 1998
-
$18.20 M(+4.0%)
Dec 1997
$17.50 M(+548.1%)
$17.50 M(+548.1%)
Dec 1996
$2.70 M(+58.8%)
$2.70 M(+58.8%)
Dec 1995
$1.70 M(-5.6%)
$1.70 M(-5.6%)
Dec 1994
$1.80 M(0.0%)
-
Feb 1994
-
$1.80 M
Feb 1994
$1.80 M
-

FAQ

  • What is Trinity Biotech annual total liabilities?
  • What is the all time high annual total liabilities for Trinity Biotech?
  • What is Trinity Biotech annual total liabilities year-on-year change?
  • What is Trinity Biotech quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Trinity Biotech?
  • What is Trinity Biotech quarterly total liabilities year-on-year change?

What is Trinity Biotech annual total liabilities?

The current annual total liabilities of TRIB is $83.38 M

What is the all time high annual total liabilities for Trinity Biotech?

Trinity Biotech all-time high annual total liabilities is $149.79 M

What is Trinity Biotech annual total liabilities year-on-year change?

Over the past year, TRIB annual total liabilities has changed by -$10.90 M (-11.56%)

What is Trinity Biotech quarterly total liabilities?

The current quarterly total liabilities of TRIB is $123.79 M

What is the all time high quarterly total liabilities for Trinity Biotech?

Trinity Biotech all-time high quarterly total liabilities is $154.70 M

What is Trinity Biotech quarterly total liabilities year-on-year change?

Over the past year, TRIB quarterly total liabilities has changed by +$42.70 M (+52.67%)